These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 21762101)

  • 1. Towards a multimodal treatment of depression: a minireview on the potential role of antibiotics.
    Yulug B; Schäbitz WR
    Mini Rev Med Chem; 2011 Oct; 11(11):984-7. PubMed ID: 21762101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroprotective potential of ceftriaxone in in vitro models of stroke.
    Lipski J; Wan CK; Bai JZ; Pi R; Li D; Donnelly D
    Neuroscience; 2007 May; 146(2):617-29. PubMed ID: 17363173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroprotective effect of ceftriaxone on the penumbra in a rat venous ischemia model.
    Inui T; Alessandri B; Heimann A; Nishimura F; Frauenknecht K; Sommer C; Kempski O
    Neuroscience; 2013 Jul; 242():1-10. PubMed ID: 23523747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain-derived neurotrophic factor, stress and depression: a minireview.
    Yuluğ B; Ozan E; Gönül AS; Kilic E
    Brain Res Bull; 2009 Mar; 78(6):267-9. PubMed ID: 19111910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relevance of core body temperatures in post-stroke depression sufferers.
    Prasad H
    Med Hypotheses; 2009 Feb; 72(2):226-7. PubMed ID: 19054625
    [No Abstract]   [Full Text] [Related]  

  • 6. Subchronic alpha-linolenic acid treatment enhances brain plasticity and exerts an antidepressant effect: a versatile potential therapy for stroke.
    Blondeau N; Nguemeni C; Debruyne DN; Piens M; Wu X; Pan H; Hu X; Gandin C; Lipsky RH; Plumier JC; Marini AM; Heurteaux C
    Neuropsychopharmacology; 2009 Nov; 34(12):2548-59. PubMed ID: 19641487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Nicotine as an antidepressant and regulator of sleep in subjects with depression].
    Vieyra-Reyes P; Venebra-Muñoz A; Rivas-Santiago B; García-García F
    Rev Neurol; 2009 Dec 16-31; 49(12):661-7. PubMed ID: 20013719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adult hippocampal neurogenesis: an actor in the antidepressant-like action.
    Mendez-David I; Hen R; Gardier AM; David DJ
    Ann Pharm Fr; 2013 May; 71(3):143-9. PubMed ID: 23622692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using neuroimaging to evaluate and guide pharmacological and psychotherapeutic treatments for mood disorders in children.
    Singh MK; Garrett AS; Chang KD
    CNS Spectr; 2015 Aug; 20(4):359-68. PubMed ID: 25659836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of corticotropin-releasing hormone in the pathophysiology of depression: therapeutic implications.
    Lloyd RB; Nemeroff CB
    Curr Top Med Chem; 2011; 11(6):609-17. PubMed ID: 21261589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of norepinephrine in the pathophysiology and treatment of mood disorders.
    Ressler KJ; Nemeroff CB
    Biol Psychiatry; 1999 Nov; 46(9):1219-33. PubMed ID: 10560027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Towards translational rodent models of depression.
    O'Leary OF; Cryan JF
    Cell Tissue Res; 2013 Oct; 354(1):141-53. PubMed ID: 23525777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Post-stroke infections and preventive antibiotics in stroke: Update of clinical evidence.
    Vermeij JD; Westendorp WF; van de Beek D; Nederkoorn PJ
    Int J Stroke; 2018 Dec; 13(9):913-920. PubMed ID: 30175940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rodent models in depression research: classical strategies and new directions.
    Pollak DD; Rey CE; Monje FJ
    Ann Med; 2010 May; 42(4):252-64. PubMed ID: 20367120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circadian rhythms and treatment implications in depression.
    Monteleone P; Martiadis V; Maj M
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Aug; 35(7):1569-74. PubMed ID: 20691746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroprotective effects of pretreatment with macrolide antibiotics on cerebral ischemia reperfusion injury.
    Inaba T; Katayama Y; Ueda M; Nito C
    Neurol Res; 2015 Jun; 37(6):514-24. PubMed ID: 25591422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of the EEG in measuring therapeutic drug action: focus on depression and antidepressants.
    Alhaj H; Wisniewski G; McAllister-Williams RH
    J Psychopharmacol; 2011 Sep; 25(9):1175-91. PubMed ID: 21106608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiapoptotic and neurotrophic effects of antidepressants: a review of clinical and experimental studies.
    Drzyzga ŁR; Marcinowska A; Obuchowicz E
    Brain Res Bull; 2009 Jun; 79(5):248-57. PubMed ID: 19480984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improvement of Antioxidant Defences and Mood Status by Oral GABA Tea Administration in a Mouse Model of Post-Stroke Depression.
    Daglia M; Di Lorenzo A; Nabavi SF; Sureda A; Khanjani S; Moghaddam AH; Braidy N; Nabavi SM
    Nutrients; 2017 Apr; 9(5):. PubMed ID: 28468264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sex differences in animal models of depression and antidepressant response.
    Dalla C; Pitychoutis PM; Kokras N; Papadopoulou-Daifoti Z
    Basic Clin Pharmacol Toxicol; 2010 Mar; 106(3):226-33. PubMed ID: 20050844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.